A citation-based method for searching scientific literature

Kathleen H Ang, Jennifer L Sherr. Expert Opin Drug Deliv 2017
Times Cited: 4







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
89
50

A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.
Steve Edelman, Satish Garg, Juan Frias, David Maggs, Yan Wang, Bei Zhang, Susan Strobel, Karen Lutz, Orville Kolterman. Diabetes Care 2006
99
50




Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
412
50

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
190
50


Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.
Bruce A Perkins, David Z I Cherney, Helen Partridge, Nima Soleymanlou, Holly Tschirhart, Bernard Zinman, Nora M Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl,[...]. Diabetes Care 2014
164
50

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
50

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.
Jason H Y Wu, Celine Foote, Juuso Blomster, Tadashi Toyama, Vlado Perkovic, Johan Sundström, Bruce Neal. Lancet Diabetes Endocrinol 2016
270
25

Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.
Ravi Retnakaran, Caroline K Kramer, Haysook Choi, Balakumar Swaminathan, Bernard Zinman. Diabetes Care 2014
77
25

Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
Rozita H Anderberg, Jennifer E Richard, Kim Eerola, Lorena López-Ferreras, Elin Banke, Caroline Hansson, Hans Nissbrandt, Filip Berqquist, Fiona M Gribble, Frank Reimann,[...]. Diabetes 2017
41
25

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.
Juris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A Menge, Thomas Forst, Christoph Kapitza. Diabetes Care 2015
160
25

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
Claresa Levetan, Laura L Want, Christian Weyer, Susan A Strobel, John Crean, Yan Wang, David G Maggs, Orville G Kolterman, Manju Chandran, Sunder R Mudaliar,[...]. Diabetes Care 2003
106
25

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow,[...]. Lancet Diabetes Endocrinol 2016
72
25


Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight.
J Jelsing, N Vrang, G Hansen, K Raun, M Tang-Christensen, L Bjerre Knudsen. Diabetes Obes Metab 2012
111
25

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
100
25

Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
Nitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, Jane Lyons Patterson, Andrea Traina, Antoine Makdissi, Paresh Dandona. Endocr Pract 2013
55
25

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.
Yutaka Seino, Shizuka Kaneko, Shuichi Fukuda, Takeshi Osonoi, Toshihiko Shiraiwa, Keiji Nishijima, Heidrun Bosch-Traberg, Kohei Kaku. J Diabetes Investig 2016
41
25


The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
B Nyholm, L Orskov, K Y Hove, C H Gravholt, N Møller, K G Alberti, C Moyses, O Kolterman, O Schmitz. Metabolism 1999
83
25

Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis.
Jennifer Sherr, Eva Tsalikian, Larry Fox, Bruce Buckingham, Stuart Weinzimer, William V Tamborlane, Neil H White, Ana Maria Arbelaez, Craig Kollman, Katrina J Ruedy,[...]. Diabetes Care 2014
24
25

Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
Sven Pörksen, Lotte B Nielsen, Anne Kaas, Mirjana Kocova, Francesco Chiarelli, Cathrine Orskov, Jens J Holst, Kenneth B Ploug, Philip Hougaard, Lars Hansen,[...]. J Clin Endocrinol Metab 2007
31
25


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
25


Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Jennifer L Sherr, Neha S Patel, Camille I Michaud, Miladys M Palau-Collazo, Michelle A Van Name, William V Tamborlane, Eda Cengiz, Lori R Carria, Eileen M Tichy, Stuart A Weinzimer. Diabetes Care 2016
42
25

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Fred Whitehouse, Davida F Kruger, Mark Fineman, Larry Shen, James A Ruggles, David G Maggs, Christian Weyer, Orville G Kolterman. Diabetes Care 2002
185
25

Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
13
25

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Stuart A Weinzimer, Garry M Steil, Karena L Swan, Jim Dziura, Natalie Kurtz, William V Tamborlane. Diabetes Care 2008
316
25

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
46
25

Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.
Ling Hinshaw, Michele Schiavon, Vikash Dadlani, Ashwini Mallad, Chiara Dalla Man, Adil Bharucha, Rita Basu, Jennifer R Geske, Rickey E Carter, Claudio Cobelli,[...]. J Clin Endocrinol Metab 2016
20
25

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43
25

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
71
25

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.
Siri Fredheim, Marie-Louise M Andersen, Sven Pörksen, Lotte B Nielsen, Christian Pipper, Lars Hansen, Jens J Holst, Jane Thomsen, Jesper Johannesen, Henrik B Mortensen,[...]. Diabetologia 2015
14
25

Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
M M Smits, L Tonneijck, M H A Muskiet, M H H Kramer, D L Cahen, D H van Raalte. Diabetes Obes Metab 2016
39
25

Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.
Ticiana C Rodrigues, Adrienne M Veyna, Michelle D Haarhues, Gregory L Kinney, Marian Rewers, Janet K Snell-Bergeon. Diabetes Technol Ther 2011
23
25


Hypoglycemia in type 1 diabetes.
Rory J McCrimmon, Robert S Sherwin. Diabetes 2010
105
25

Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis.
Vardhman K Rakyan, Huriya Beyan, Thomas A Down, Mohammed I Hawa, Siarhei Maslau, Deeqo Aden, Antoine Daunay, Florence Busato, Charles A Mein, Burkhard Manfras,[...]. PLoS Genet 2011
202
25

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.
Christopher T Brown, Austin G Davis-Richardson, Adriana Giongo, Kelsey A Gano, David B Crabb, Nabanita Mukherjee, George Casella, Jennifer C Drew, Jorma Ilonen, Mikael Knip,[...]. PLoS One 2011
409
25

Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes.
J F Gautier, C Wilson, C Weyer, D Mott, W C Knowler, M Cavaghan, K S Polonsky, C Bogardus, R E Pratley. Diabetes 2001
91
25

Intrauterine Programming of Diabetes and Adiposity.
Ashutosh Singh Tomar, Divya Sri Priyanka Tallapragada, Suraj Singh Nongmaithem, Smeeta Shrestha, Chittaranjan S Yajnik, Giriraj Ratan Chandak. Curr Obes Rep 2015
23
25

The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins.
Elsa Pinto, Marisol Anselmo, Manuela Calha, Andrew Bottrill, Isabel Duarte, Peter W Andrew, Maria L Faleiro. Microbiology (Reading) 2017
24
25

The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.
Farah A Meah, Linda A DiMeglio, Carla J Greenbaum, Janice S Blum, Jay M Sosenko, Alberto Pugliese, Susan Geyer, Ping Xu, Carmella Evans-Molina. Diabetologia 2016
22
25

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
L Masmiquel, L A Leiter, J Vidal, S Bain, J Petrie, E Franek, I Raz, A Comlekci, S Jacob, L van Gaal,[...]. Cardiovasc Diabetol 2016
27
25

Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls.
Simon E Regnell, Pernilla Peterson, Lena Trinh, Per Broberg, Peter Leander, Åke Lernmark, Sven Månsson, Helena Elding Larsson. Metabolism 2015
21
25

Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity.
Marc Y Donath, Élise Dalmas, Nadine S Sauter, Marianne Böni-Schnetzler. Cell Metab 2013
189
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.